Clinical Trials Browser

Phase 1 × Neoplasms × vadimezan × Clear all

NCT01031212 2013-05-13

ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors

Phase 1 Withdrawn

Neoplasms

NCT00856336 2009-03-05

DART

Phase 1 Completed

Neoplasms